SE0303451D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0303451D0
SE0303451D0 SE0303451A SE0303451A SE0303451D0 SE 0303451 D0 SE0303451 D0 SE 0303451D0 SE 0303451 A SE0303451 A SE 0303451A SE 0303451 A SE0303451 A SE 0303451A SE 0303451 D0 SE0303451 D0 SE 0303451D0
Authority
SE
Sweden
Prior art keywords
new compounds
relates
present
compounds
dimethylbenzylamino
Prior art date
Application number
SE0303451A
Other languages
English (en)
Inventor
Tesfai Sebhatu
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30768770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0303451(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0303451A priority Critical patent/SE0303451D0/sv
Publication of SE0303451D0 publication Critical patent/SE0303451D0/sv
Priority to TW093139011A priority patent/TW200526659A/zh
Priority to AU2004299435A priority patent/AU2004299435B2/en
Priority to KR1020067011954A priority patent/KR20060125803A/ko
Priority to PCT/SE2004/001909 priority patent/WO2005058895A1/en
Priority to JP2006545292A priority patent/JP2007514744A/ja
Priority to RU2006123362/04A priority patent/RU2376306C2/ru
Priority to DE602004031556T priority patent/DE602004031556D1/de
Priority to AT04809082T priority patent/ATE499371T1/de
Priority to ES04809082T priority patent/ES2359829T3/es
Priority to EP04809082A priority patent/EP1697360B1/en
Priority to CN2004800379883A priority patent/CN1894246B/zh
Priority to MYPI20045189A priority patent/MY140450A/en
Priority to UAA200605707A priority patent/UA84443C2/ru
Priority to BRPI0417640-5A priority patent/BRPI0417640A/pt
Priority to CA002549144A priority patent/CA2549144A1/en
Priority to MXPA06006708A priority patent/MXPA06006708A/es
Priority to US10/582,838 priority patent/US7459463B2/en
Priority to UY28676A priority patent/UY28676A1/es
Priority to ARP040104749A priority patent/AR046956A1/es
Priority to IL175957A priority patent/IL175957A0/en
Priority to ZA200604633A priority patent/ZA200604633B/en
Priority to CO06059763A priority patent/CO5721004A2/es
Priority to NO20063309A priority patent/NO20063309L/no
Priority to HK07101019.8A priority patent/HK1095810A1/xx
Priority to JP2012010610A priority patent/JP2012102143A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0303451A 2003-12-18 2003-12-18 New compounds SE0303451D0 (sv)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE0303451A SE0303451D0 (sv) 2003-12-18 2003-12-18 New compounds
TW093139011A TW200526659A (en) 2003-12-18 2004-12-15 New compounds
MXPA06006708A MXPA06006708A (es) 2003-12-18 2004-12-16 Nuevas formas cristalinas de sal de mesilato de 2, 3-dimetil-8-(2, 6-dimetilbencilamino) -n-hidroxietil-imidazo [1, 2-a] piridin-6 -carboxamida.
US10/582,838 US7459463B2 (en) 2003-12-18 2004-12-16 Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt
CN2004800379883A CN1894246B (zh) 2003-12-18 2004-12-16 2,3-二甲基-8-(2,6-二甲基苄基氨基)-N-羟乙基-咪唑并[1,2-a]吡啶-6-羧酰胺甲磺酸盐的新晶形
UAA200605707A UA84443C2 (ru) 2003-12-18 2004-12-16 Кристаллическая форма 2,3-диметил-8-(2,6-диметилбензиламино)-n-гидроксиэтилимидазо[1,2-а]пиридин-6-карбоксамид мезилата (варианты), способ их получения, фармацевтическая композиция и способ лечения желудочно-кишечных расстройств
PCT/SE2004/001909 WO2005058895A1 (en) 2003-12-18 2004-12-16 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt.
JP2006545292A JP2007514744A (ja) 2003-12-18 2004-12-16 ２，３−ジメチル−８−（２，６−ジメチルベンジルアミノ）−Ｎ−ヒドロキシエチル−イミダゾ［１，２−ａ］ピリジン−６−カルボキシアミドメシラート塩の新規な結晶形
RU2006123362/04A RU2376306C2 (ru) 2003-12-18 2004-12-16 НОВЫЕ КРИСТАЛЛИЧЕСКИЕ ФОРМЫ СОЛИ МЕЗИЛАТА 2,3-ДИМЕТИЛ-8-(2, 6-ДИМЕТИЛБЕНЗИЛАМИНО)-N-ГИДРОКСИЭТИЛ-ИМИДАЗО[1, 2-a]ПИРИДИН-6-КАРБОКСАМИДА, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ ИХ, ИХ ПРИМЕНЕНИЕ И СПОСОБ ЛЕЧЕНИЯ
DE602004031556T DE602004031556D1 (de) 2003-12-18 2004-12-16 Neue kristalline formen von 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethylimidazoä1,2-aüpyridin-6-carbonsäureamidmesylatsalz
AT04809082T ATE499371T1 (de) 2003-12-18 2004-12-16 Neue kristalline formen von 2,3-dimethyl-8-(2,6- dimethylbenzylamino)-n-hydroxyethylimidazoä1,2- aüpyridin-6-carbonsäureamidmesylatsalz
ES04809082T ES2359829T3 (es) 2003-12-18 2004-12-16 Nuevas formas cristalinas de la sal mesilato de 2,3-dimetil-8-(2,6-dimetilbencilamino)-n-hidroxietil-imidazo-[1,2-a]piridin-6-carboxamida.
EP04809082A EP1697360B1 (en) 2003-12-18 2004-12-16 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo 1, 2-a pyridine-6-carboxamide mesylate salt.
AU2004299435A AU2004299435B2 (en) 2003-12-18 2004-12-16 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -N-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt.
MYPI20045189A MY140450A (en) 2003-12-18 2004-12-16 New crystalline forms of 2, 3 dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo [1,2-a] pyridine-6-carboxamide mesylate salt
KR1020067011954A KR20060125803A (ko) 2003-12-18 2004-12-16 2,3-디메틸-8-(2,6-디메틸벤질아미노)-Ｎ-히드록시에틸-이미다조[1,2-ａ]피리딘-6-카르복스아미드 메실레이트 염의신규 결정질 형태
BRPI0417640-5A BRPI0417640A (pt) 2003-12-18 2004-12-16 composto, processos para preparação de forma a e de forma b formulação farmacêutica, uso de composto, e, método de tratamento de distúrbio gastrointestinais
CA002549144A CA2549144A1 (en) 2003-12-18 2004-12-16 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt
ARP040104749A AR046956A1 (es) 2003-12-18 2004-12-17 Formas cristalinas de la sal mesilato de 2,3- dimetil-8-(2,6-dimetilbencilamino)-n-hidroxietil-imidazo(1,2-a)piridin-6-carboxamida
UY28676A UY28676A1 (es) 2003-12-18 2004-12-17 Nuevos compuestos
IL175957A IL175957A0 (en) 2003-12-18 2006-05-25 Novel crystalline forms of 2,3 dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt
ZA200604633A ZA200604633B (en) 2003-12-18 2006-06-06 Novel crystalline forms of 2,3 dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazol[1,2-a]pyridine-6-carboxamide mesylate salt
CO06059763A CO5721004A2 (es) 2003-12-18 2006-06-20 Formas cristalinas novedosas de la sal de mesilato de 2,3-dimetil-8-(2,6-dimetilbencilamino)-n-hidroxietil-imidazol[1,2-a]piridin-6-carboxamida
NO20063309A NO20063309L (no) 2003-12-18 2006-07-17 Nye krystallinske former av 2,3-dimetyl-8-(2,6-dimetylbenzylamino)-N-hydroksyetyl-imidazo[1,2-A]pyridin-6-karboksamid mesylatsalt
HK07101019.8A HK1095810A1 (sv) 2003-12-18 2007-01-29
JP2012010610A JP2012102143A (ja) 2003-12-18 2012-01-23 ２，３−ジメチル−８−（２，６−ジメチルベンジルアミノ）−Ｎ−ヒドロキシエチル−イミダゾ［１，２−ａ］ピリジン−６−カルボキシアミドメシラート塩の新規な結晶形

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303451A SE0303451D0 (sv) 2003-12-18 2003-12-18 New compounds

Publications (1)

Publication Number Publication Date
SE0303451D0 true SE0303451D0 (sv) 2003-12-18

Family

ID=30768770

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303451A SE0303451D0 (sv) 2003-12-18 2003-12-18 New compounds

Country Status (25)

Country Link
US (1) US7459463B2 (sv)
EP (1) EP1697360B1 (sv)
JP (2) JP2007514744A (sv)
KR (1) KR20060125803A (sv)
CN (1) CN1894246B (sv)
AR (1) AR046956A1 (sv)
AT (1) ATE499371T1 (sv)
AU (1) AU2004299435B2 (sv)
BR (1) BRPI0417640A (sv)
CA (1) CA2549144A1 (sv)
CO (1) CO5721004A2 (sv)
DE (1) DE602004031556D1 (sv)
ES (1) ES2359829T3 (sv)
HK (1) HK1095810A1 (sv)
IL (1) IL175957A0 (sv)
MX (1) MXPA06006708A (sv)
MY (1) MY140450A (sv)
NO (1) NO20063309L (sv)
RU (1) RU2376306C2 (sv)
SE (1) SE0303451D0 (sv)
TW (1) TW200526659A (sv)
UA (1) UA84443C2 (sv)
UY (1) UY28676A1 (sv)
WO (1) WO2005058895A1 (sv)
ZA (1) ZA200604633B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004285394B2 (en) * 2003-11-03 2009-01-08 Astrazeneca Ab Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux
FI20086158A0 (sv) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidazopyridinederivater

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4040632A1 (de) * 1990-12-19 1992-06-25 Kali Chemie Pharma Gmbh Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
SE512531C2 (sv) * 1997-09-04 2000-03-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
SE0100295D0 (sv) 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
KR20040058103A (ko) 2001-02-13 2004-07-03 아스트라제네카 아베 신규 개질 방출 제제
KR20050007476A (ko) * 2002-05-07 2005-01-18 알타나 파마 아게 기도 질환 치료를 위한 가역적 양성자 펌프 억제제와 기도치료제의 신규 조합물

Also Published As

Publication number Publication date
KR20060125803A (ko) 2006-12-06
JP2007514744A (ja) 2007-06-07
CO5721004A2 (es) 2007-01-31
EP1697360B1 (en) 2011-02-23
ZA200604633B (en) 2007-04-25
JP2012102143A (ja) 2012-05-31
MXPA06006708A (es) 2006-08-18
BRPI0417640A (pt) 2007-03-27
CN1894246A (zh) 2007-01-10
US7459463B2 (en) 2008-12-02
HK1095810A1 (sv) 2007-05-18
TW200526659A (en) 2005-08-16
UA84443C2 (ru) 2008-10-27
UY28676A1 (es) 2005-07-29
MY140450A (en) 2009-12-31
US20070112021A1 (en) 2007-05-17
AU2004299435A1 (en) 2005-06-30
IL175957A0 (en) 2006-10-05
RU2376306C2 (ru) 2009-12-20
EP1697360A1 (en) 2006-09-06
AU2004299435B2 (en) 2008-04-17
ATE499371T1 (de) 2011-03-15
AR046956A1 (es) 2006-01-04
CN1894246B (zh) 2011-06-22
ES2359829T3 (es) 2011-05-27
DE602004031556D1 (de) 2011-04-07
NO20063309L (no) 2006-09-14
RU2006123362A (ru) 2008-01-27
WO2005058895A1 (en) 2005-06-30
CA2549144A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
EP1887007A3 (en) Imidazo- and Thiazolopyridine as JAK3 Kinase Inhibitors
IL187438A0 (en) Pyrrolopyridine derivatives and pharmaceutical compositions containing the same
ES2340502T3 (es) Compuestos de 1,4,8-triazaespiro(4,5)decan-2-ona sustituidos para el tratamiento de la obesidad.
AP2005003424A0 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders; process for their preparation and pharmaceutical compositions containing them.
ATE404552T1 (de) Substituierte isochinolinderivate und anwendungsverfahren
WO2003095455A3 (en) Substituted pyrazolopyrimidines
SE0300119D0 (sv) Novel compounds
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
IS8377A (is) Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
ECSP067111A (es) Derivados de pirido-pirimidina, su preparación, su aplicación en terapéutica
SI1869038T1 (sl) Substituirane 5,6,7,8-tetrahidro-imidazo(1,2-a)piridin-2-ilaminske spojine in njihova uporaba za pripravo zdravil
WO2005055943A3 (en) Vinorelbine derivatives
SE0401763D0 (sv) Compounds
EP1617806A4 (en) SELECTIVE SPIROCYCLIC GLUCOCORTICOID RECEPTOR MODULATORS
SE0100296D0 (sv) New compounds
SE0303451D0 (sv) New compounds
SE0100297D0 (sv) New compounds
SE0100295D0 (sv) New compounds
WO2002044128A3 (en) Salicylate analogs as interleukin-4 antagonists